GeneMedi

GeneMedi is a private China-based biotechnology company focused on discovery, design, and manufacturing solutions for diagnostics, biologics, and gene therapy research and development. The company sells recombinant proteins, antibodies, assay reagents, viral vectors, AAV purification and titration tools, and related development services for therapeutic and diagnostic applications. Its stated platform capabilities include TAURUS for antibody discovery, LIBRA for AI-driven protein evolution, and G-NEXT for next-generation AAV vector discovery and engineering. GeneMedi appears to operate primarily as a commercial life-science tools, CRO, and manufacturing-services company rather than as a clinical-stage drug developer with a disclosed therapeutic pipeline. Its offerings span diagnostics, therapeutic antibody and ADC analytical support, gene therapy vector development, and cell-therapy-enabling tools.